Spero Therapeutics Inc (SPRO) has fallen Monday morning, with the stock losing -3.36% in pre-market trading to 1.15. SPRO's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, SPRO ranks higher than 42% of stocks. Spero Therapeutics Inc has risen 11.21% over the past month, closing at $1.05 on October 23. During this period of time, the stock fell as low as $1.00 and as high as $1.29. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
SPRO has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on SPRO!